Abstract: Compounds which are FK228 analogues of the general formula (I) or (I?), isosteres thereof and pharmaceutically acceptable salts thereof are found to inhibit HDAC wherein R1, R2, R3 and R4 are the same or different and represent an amino acid side chain moiety and each R6 is the same or different and represents hydrogen or C1-C4 alkyl.
Type:
Grant
Filed:
June 2, 2006
Date of Patent:
July 12, 2011
Assignee:
University of Southampton Highfield
Inventors:
Arasu Ganesan, Graham Keith Packham, Alexander Yurek-George, Alexander Richard Liam Cecil
Abstract: The present invention provides the use of IFN-?, an agent that increases the expression of IFN-?, or a polynucleotide which is capable of expressing IFN-? or said agent for the manufacture of a medicament for the treatment of rhinovirus-induced exacerbation of a respiratory disease selected from asthma and chronic obstructive pulmonary disease, wherein said treatment is by airway delivery of said medicament, e.g. by use of an aerosol nebuliser. Also provided is IFN-? for the same purpose.
Type:
Application
Filed:
September 8, 2006
Publication date:
June 14, 2007
Applicants:
University of Southampton Highfield, Imperial Innovations Limited
Inventors:
Donna Davies, Peter Wark, Stephen Holgate, Sebastian Johnston